AC
GOSS icon

AXQ Capital’s Gossamer Bio GOSS Stock Holding History

AXQ Capital’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-20,421
Closed -$6.71K – 1122
2026
Q1 		$6.71K Sell
20,421
-42,696
-68% -$67.1K ﹤0.01% 973
2025
Q4 		$196K Buy
63,117
+16,750
+36% +$47.8K 0.04% 574
2025
Q3 		$122K Buy
+46,367
New +$102K 0.05% 502
2023
Q1 		– Sell
-16,372
Closed -$35.5K – 543
2022
Q4 		$35.5K Buy
+16,372
New +$135K 0.02% 313

Other funds holding GOSS

D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
DIG
DeepCurrents Investment Group New York $3.3B AUM 12.57% 1-Year Est. Return
CCM
Context Capital Management Lajolla, California $5.15B AUM 1.28% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $44.3M AUM 34.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.65% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $174M AUM

AXQ Capital's GOSS Position: Q2 2026 in Review

AXQ Capital sold out of Gossamer Bio (GOSS) in Q2 2026, closing a stake of 20,421 shares — an estimated $6.71K sold.

AXQ Capital first reported a position in GOSS in Q4 2022 and held it in 4 quarters. The position peaked at $196K in Q4 2025. 170 funds tracked by Wall St. Rank hold GOSS as of Q2 2026.

  • AXQ Capital reported no remaining Gossamer Bio position as of Q2 2026 after selling out during the quarter.
  • AXQ Capital sold 20,421 Gossamer Bio shares in Q2 2026, an estimated $6.71K.
  • AXQ Capital first reported a position in Gossamer Bio in Q4 2022 and held it in 4 quarters.
  • AXQ Capital's Gossamer Bio position peaked at $196K in Q4 2025.
  • 170 funds tracked by Wall St. Rank held Gossamer Bio as of Q2 2026.

Based on AXQ Capital's 13F filing for Q2 2026, filed 6 Aug 2026.